NEW YORK (GenomeWeb) – PerkinElmer announced Tuesday it has signed an agreement to serve as the exclusive collaborator with China's National Health and Family Planning Commission to create and implement a newborn screening training program focused on rural China.

Under the three-year agreement, PerkinElmer will provide its diagnostic tests and expertise to develop and roll out a program that will "substantially increase adoption and access to newborn screening in China," the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.